Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zavacorilant by Corcept Therapeutics for Alzheimer's Disease: Likelihood of Approval
Zavacorilant is under clinical development by Corcept Therapeutics and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Zavacorilant by Corcept Therapeutics for Huntington Disease: Likelihood of Approval
Zavacorilant is under clinical development by Corcept Therapeutics and currently in Phase I for Huntington Disease. According to GlobalData, Phase...
Zavacorilant by Corcept Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Zavacorilant is under clinical development by Corcept Therapeutics and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...